Cancer ResearchMar 01, 2021By Mel J. YeatesFDA approves PepaxtoOncopeptides’ Pepaxto has been approved for patients with triple-class refractory multiple myeloma
Cancer ResearchFeb 09, 2021By DDNews StaffFDA approves Libtayo for basal cell carcinomaLibtayo receives full approval in locally advanced BCC and accelerated approval in metastatic BCC
Business & Policy NewsFeb 03, 2021By DDNews StaffFDA approves new treatment for NSCLCFDA approves Tepmetko as a once-daily oral MET inhibitor for NSCLC with METex14 skipping alterations
Other Internal MedicineJan 25, 2021By DDNews StaffAdditional EU approvals for RINVOQThe European Commission has approved AbbVie’s RINVOQ (upadacitinib) for treatment of psoriatic arthritis and ankylosing spondylitis
Infectious Disease & VaccinesDec 08, 2020By Mel J. YeatesBNT162b2 becomes first authorized COVID-19 vaccinePfizer and BioNTech have achieved the first authorization for a vaccine against COVID-19